Reactive · Zwitterionic Antifouling Copolymer

Poly(NHSMA-co-MPC)

Also written P(NHSMA-co-MPC), NHSMA-MPC copolymer  |  Custom composition — no single CAS

A random copolymer of N-hydroxysuccinimide methacrylate (NHSMA) and MPC (2-methacryloyloxyethyl phosphorylcholine). MPC makes up the majority of the chain, giving the polymer a strongly hydrated, low-fouling zwitterionic background; NHSMA is included as a minor, sparsely distributed comonomer, each unit carrying a reactive NHS ester. The result is a low-fouling scaffold that stays “conjugation-ready” — react the NHS sites with an amine-bearing ligand, antibody, dye, or drug without disturbing the antifouling character of the rest of the chain.

Custom composition

(C₈H₉NO₄)ₘ-co-(C₁₀H₂₀NO₆P)ₙ

Poly(NHSMA-co-MPC)

Appearance: White to off-white powder
Character: Antifouling + amine-reactive
Architecture: Random copolymer
Storage−20 °C, desiccated, dark

ISO 9001:2015

Manufactured under certified quality management

Custom NHSMA:MPC Ratio

Reactive-site density tuned independently of antifouling background

Batch-Level COA

Mn, Đ, composition, and NHS-ester activity per lot

Desiccated Cold-Chain Packaging

Preserves NHS-ester reactivity in transit and storage

CAS No.

Composition-dependent

Molecular Formula

(C₈H₉NO₄)ₘ-co-(C₁₀H₂₀NO₆P)ₙ

Character

Antifouling + amine-reactive

Mn Range

10K – 120K

Form

Powder

A stealth background with a few reactive handles

MPC and NHSMA aren't playing the same role here — one is the bulk material, the other is a sparse functional handle riding on top of it.

MPC: the antifouling majority

The phosphorylcholine zwitterion hydrates strongly and resists nonspecific protein and cell adsorption at every pH — this is what most of the chain is doing.

NHSMA: the sparse reactive minority

Each NHS ester reacts with a primary amine to install exactly one ligand, dye, or biomolecule per site — a small fraction of units is usually enough.

Ratio protects the antifouling character

Keeping NHSMA content low preserves the dense, hydrated MPC background; too much reactive comonomer starts to compromise fouling resistance.

Couple once, keep the background intact

Reacting the NHS sites with your target amine doesn't touch the MPC units — the low-fouling behavior of the rest of the chain is unaffected.

≈2% NHSMA≈5%≈10%≈20%≈30%+ NHSMA
Maximum antifouling, few sites Typical working range More sites, reduced antifouling
Most reactive-antifouling designs in the literature sit in the 2–15 mol% NHSMA range — enough reactive sites for practical conjugation density without materially compromising the MPC background's resistance to nonspecific adsorption.

Choose the reactive-site density that fits your conjugate

NHSMA:MPC feed ratio sets how many reactive sites are available per chain, and how much that trades off against antifouling density.

NHSMA : MPC ≈ 2:98

MPC-dominant

Maximum antifouling character with just enough reactive sites for sparse, well-controlled single-ligand conjugation.

NHSMA : MPC ≈ 10:90

Balanced

A common working range — meaningful conjugation density (e.g. multiple dyes or ligands per chain) while retaining low fouling.

NHSMA : MPC ≈ 20:80

Reactive-rich

Higher reactive-site density for dense multivalent conjugation, with some reduction in antifouling performance.

Applications

Targeted stealth nanoparticles

An MPC-rich, low-fouling corona with a small number of reactive sites for attaching a targeting ligand or antibody fragment.

Biosensor capture surfaces

Low-fouling MPC background minimizes nonspecific signal, while NHS sites give oriented, covalent capture-antibody immobilization.

Diagnostic microarrays

A low-background MPC surface with defined reactive spots for spotting amine-modified capture probes.

Stealth drug-polymer conjugates

Amine-bearing drugs are coupled to the NHS sites while the MPC background extends circulation and reduces immune recognition.

Hemocompatible bioactive devices

Attach anticoagulants, growth factors, or cell-adhesion peptides onto an otherwise blood-compatible MPC surface.

Reactive antifouling coatings

Device or catheter coatings that resist protein/cell adhesion while remaining chemically addressable for later bioactive functionalization.

Cell-patterning surfaces

Sparse RGD-peptide or growth-factor coupling on an antifouling MPC background creates defined, non-fouling cell-adhesive patterns.

Zwitterionic PPM libraries

One reactive-zwitterionic precursor batch can be split and coupled to different amines to build a library of functionalized MPC-based materials.

Data & safety documents

Batch-specific COAs with GPC, composition (¹H-NMR), and NHS-ester activity data available for order confirmations. Contact us for a specific lot number.

Safety Data Sheet

GHS-format · EN / ZH

Certificate of Analysis

Ratio + Mw confirmation

Amine Coupling Protocol

Recommended buffers & conditions

FAQ

Most frequent questions and answers

It’s used wherever you need a low-fouling, biocompatible surface or particle that still needs to carry something specific — a targeting ligand, antibody, dye, or drug. The MPC background keeps nonspecific protein and cell adsorption low, while the sparse NHS sites let you attach exactly what you need without giving up that antifouling character.

MPC units are the antifouling workhorse — a permanent zwitterion that hydrates and resists nonspecific adsorption. NHSMA units are a minor, reactive comonomer — each carries an NHS ester that reacts with a primary amine. Combining them gives a low-fouling material that isn’t a dead end: it still has a defined way to attach something useful.

NHSMA is typically kept to a small minority — commonly 2–20 mol% — so the MPC background still dominates the chain’s overall behavior. Higher NHSMA content gives more reactive sites per chain but starts to reduce antifouling performance, so the ratio is chosen based on how much conjugation density you actually need.

No — MPC units don’t carry primary amines or otherwise compete for the NHS ester, so they’re chemically inert to the coupling reaction itself. The main practical consideration is the same as for any NHS-ester chemistry: work in an amine-free buffer and avoid excess water exposure before coupling.

Dissolve the polymer fresh in a dry organic solvent (or briefly in a cold, amine-free aqueous buffer, pH 7.5–8.5) and add your amine-bearing target promptly — protein, peptide, dye, or small molecule. The amine displaces the NHS leaving group to form a stable amide bond at each reacted site.

No. Plain PMPC homopolymer is purely zwitterionic with no built-in way to attach anything else. This copolymer keeps PMPC’s antifouling character as the majority component but adds a small number of NHS-reactive sites specifically so it can be conjugated to a ligand or biomolecule after the fact.

No — composition-specific random copolymers like this one are not assigned a single CAS Registry Number, since the NHSMA:MPC ratio, Mn, and dispersity are set per synthesis batch. Each lot’s COA documents the actual composition and NHS-ester activity.

Store sealed, desiccated, at −20 °C, protected from light and moisture — the NHS ester is sensitive to both heat and humidity, just as in the NHSMA homopolymer. Allow the container to reach room temperature before opening, dissolve fresh, and react promptly for best coupling efficiency.

Need a specific NHSMA:MPC ratio, or a pre-conjugated version?

Our technical sales team responds within one business day.